BUCELLI, CRISTINA

BUCELLI, CRISTINA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Anagrelide and Mutational Status in Essential Thrombocythemia 1-giu-2016 D. CattaneoN. OrofinoC. BucelliS. FabrisA. Cortelezzi + Article (author) -
Comprehensive Molecular Analyses in a Case of Masked Philadelphia Chronic Myeloid Leukemia 1-gen-2015 Cattaneo D.Bucelli C. + Article (author) -
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series 1-gen-2020 Cattaneo D.Bucelli C.Croci G. A.Cortinovis I.Rosti V.Martino B.Baldini L.Gianelli U. + Article (author) -
Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients : a real clinical problem? 1-ott-2015 Cattaneo D.Bucelli C.Orofino N.Grancini V.Cortelezzi A. + Article (author) -
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 14-lug-2020 Fattizzo, BrunoGiannotta, Juri AlessandroBarbanti, Maria ChiaraBucelli, CristinaCassin, RamonaCattaneo, DanieleCavallaro, FrancescaFerla, ValeriaFracchiolla, Nicola StefanoMattiello, VeronicaNeri, AntoninoNoto, AlessandroOnida, FrancescoPasquale, RaffaellaPettine, LoredanaReda, GianluigiRossi, Francesca GaiaSaporiti, Giorgia NatasciaSciumè, MariaritaBaldini, Luca + Article (author) -
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 20-ott-2017 C. BucelliD. CattaneoA. Cortelezzi + Article (author) -
Imatinib and ruxolitinib association : first experience in two patients 1-giu-2014 U. GianelliD. CattaneoF. BindaC. BucelliA. Cortelezzi + Article (author) -
Impact on thrombotic risk of canonical and atypical CALR mutations in essential thrombocythemia. A single-center cohort study 1-gen-2022 Fabris S.Cattaneo D.Bucelli C.Ciceri G.Pasquale R.Todoerti K.Gianelli U.Baldini L.Neri A. + Article (author) -
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis : a practical approach 1-ott-2019 Cattaneo D.Bossi A.Cortinovis I.Bucelli C.Orofino N.Fabris S.Baldini L.Gianelli U. + Article (author) -
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients : A Safe and Effective Option 1-mag-2018 Cattaneo D.Orofino N.Bucelli C. + Article (author) -
Management of Myelofibrosis : from Diagnosis to New Target Therapies 30-apr-2020 Cattaneo D.Bucelli C. + Article (author) -
New perspectives on polycythemia vera : from diagnosis to therapy 13-ago-2020 Cattaneo D.Bucelli C.Baldini L. + Article (author) -
Osteolytic lesions in primary myelofibrosis and effect of ruxolitinib therapy : Report of a case and literature review 1-gen-2018 Bucelli C.Cattaneo D.Valli V. B.Levati G. V.Lonati S.Gianelli U. + Article (author) -
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series 1-gen-2018 D. CattaneoC. BucelliA. Cortelezzi + Article (author) -
Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemotherapy : Report of a Case 1-gen-2017 Bucelli, CCattaneo, DFerla, V + Article (author) -
Prognostic significance of a comprehensive histologic evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients. 1-dic-2017 U. GianelliS. FioriD. CattaneoA. BossiI. CortinovisA. BonomettiC. BucelliN. OrofinoG..P. Bulfamante + Article (author) -
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 9-lug-2020 Cattaneo D.Bucelli C. + Article (author) -
Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia 1-gen-2017 C. BucelliD. CattaneoN. OrofinoJ. A. GiannottaU. GianelliA. Cortelezzi + Article (author) -
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality 1-lug-2020 Fattizzo B.Giannotta J. A.Cattaneo D.Bucelli C.Fracchiolla N. S.Onida F.Baldini L. + Article (author) -
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 1-gen-2021 Caramella, MariannaPatriarca, AndreaBucelli, CristinaFinazzi, Maria ChiaraRambaldi, Alessandro + Article (author) -